MediWound Ltd. Stock: price and insider trades · United States

US·Mcap US$153M

MediWound Ltd.: what insiders have been doing

We have very little insider data for MediWound Ltd. so far: the most recent filing dates from 28 August 2026. With so few records, no pattern can be drawn yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Key facts

Headquarters: Yavne'el, Israel · Founded: 2001

Source: Wikidata (CC0).

Insider Decl.

Thresholds

n/a

Buy Volume

n/a

Sell Volume

n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score

Ranked 25,532 of 26,897 companies

15.7

score / 100

Value

Quality

FCF yld-11%

Earn yld-12%

EV/EBITDA·

ROE-72%

Gross mgn19%

Net mgn·

Debt/EBITDA·

Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$11.85

Analyst consensus

6 analysts

1.17/5

US$25.00Target US$30.67(+159%)US$36.00

Income statement

RevenueUS$17M

Gross profitUS$3.3M19% margin

EBITDA-US$21.5M-127% margin

Net income-US$23.9M-170.1% margin

Valuation

PER (forward)-5.2x

P/Book4.3x

Beta0.09

Balance sheet & cash

Market capUS$153M

Total debtUS$8.2M

Free Cash Flow-US$21.6M

Debt / Equity24%

Profitability & ownership

ROE-72.4%

ROA-28.6%

% insiders16.7%

% institutions55.9%

Last declaration on 28 August 2026

Declarations1 total

●
Shmulik Hess
OfficerExecutives27 Aug 2026
50,267 USD28Source
3,958 shares@ US$12.700.027% mcap100.0% of flowOrdinary SharesSEC144:0001976408-26-000783